Immunovant Inc. Common Stock vs Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) — how do they compare? Immunovant Inc. Common Stock trades at $30.38 (market cap $6.25B), while Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) trades at $6.77 (market cap $23.36B). The key difference: Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) is far larger — about 3.7× Immunovant Inc. Common Stock's market cap, and Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) pays a 0.51% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IMVT | SBS | |
|---|---|---|
Market Cap | $6.25B | $23.36B |
Volume | 1,755,411 | 17,617,579 |
Sector | Health | Utilities |
52-Week High | $44.96 | $7.08 |
52-Week Low | $17.03 | $4.45 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $5.35B | $30.17B |
Dividend Yield | — | 0.51% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Sabesp provides water supply and sewage services in the Brazilian state of São Paulo. Its shares trade in Brazil as SBSP3 and in the U.S. as NYSE-listed ADSs under SBS.
Read more on SBS →